14 February 2023
Linesight is delighted to share the recording of its recent public webinar, where a panel of experts provided an overview of the Linesight Capital Project Benchmarking programme and high-level insights that have emerged from analysis of over 168 global projects valued at US$26 billion. The programme commenced in 2020 and has grown into a global collaboration of 17 leading pharmaceutical companies benchmarking and aligning cost and schedule data across capital projects.
To view the full recording, click here.
Share
Related News
09 October 2024
Linesight appoints new lead for Australia and New Zealand
08 October 2024
Linesight appoints new Country Lead for Malaysia
24 September 2024
Linesight Australia win RICS Quantity Surveying Team of the year